Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May;58(3):147-149.
doi: 10.1007/s13139-023-00836-z. Epub 2024 Jan 18.

Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [18F]FDG PET/CT

Affiliations

Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [18F]FDG PET/CT

Ahmed Saad Abdlkadir et al. Nucl Med Mol Imaging. 2024 May.
No abstract available

Keywords: Diagnostic challenge; FDG PET/CT; Hepatic superscan; Medullary thyroid carcinoma; Skip metastasis; Unusual metastases.

PubMed Disclaimer

Conflict of interest statement

Conflict of InterestAhmed Saad Abdlkadir, Dhuha Al-Adhami, Baraa Alsyouf, Raghad Alhouwari, Ula Al- Rasheed, Issa Mohamad, and Akram Al-Ibraheem declare no conflict of interest.

Figures

Fig. 1
Fig. 1
a Maximum intensity projection image revealed evidence of hypermetabolic malignant large left thyroid lobe lesion (arrowhead), associated with few hypermetabolic metastatic mediastinal lymphadenopathy (curved arrow), several hypermetabolic bone marrow lesions (asterisks), and hypermetabolic massive hepatomegaly (i.e., hepatic superscan, arrow). b Axial PET/CT images of the neck revealed evidence of a large left thyroid lobe lesion with a maximum standardized uptake value (SUVmax) of 6.3 (arrowheads). c Axial PET/CT images of the thorax revealed evidence of a few hypermetabolic mediastinal lymph nodes (SUVmax up to 5.1; curved arrows). d Coronal PET/CT image demonstrating evidence of hepatic super scan (SUVmax 19.8; arrow) visualized concurrently with the hypermetabolic malignant left thyroid lobe tumor (arrowhead). e Axial PET/CT images demonstrating evidence of several hypermetabolic bone marrow lesions involving the left humeral shaft, S1 vertebra, and right proximal femur (SUVmax up to 8.1; asterisks). f Histopathologic examination of the ultrasound-guided liver biopsy sample revealed evidence of metastatic medullary thyroid carcinoma evidenced by positive expression for chromogranin, thyroid transcription factor-1 (TTF-1), and calcitonin immunostains

References

    1. Tamagnini P, Iacobone M, Sebag F, Marcy M, De Micco C, Henry J. Lymph node involvement in macroscopic medullary thyroid carcinoma. Br J Surg. 2005;92:449–453. doi: 10.1002/bjs.4860. - DOI - PubMed
    1. Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, et al. Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients. Cancers. 2023;15:4102. doi: 10.3390/cancers15164102. - DOI - PMC - PubMed
    1. Trybek T, Kowalska A. Does the presence of regional lymph node metastases have any impact on the complete remission rate in patients with distant metastases of papillary thyroid carcinoma (PTC), treated by radioiodine therapy? Endokrynol Pol. 2010;61:443–445. - PubMed
    1. Zhao H, Huang T, Li H. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery. 2019;166:55–60. doi: 10.1016/j.surg.2019.01.025. - DOI - PubMed
    1. Yildirim N, Dede DS, Gumuskaya B. FDG hepatic superscan due to metastatic infiltration of prostate cancer. Clin Nucl Med. 2020;45:474–476. doi: 10.1097/RLU.0000000000003044. - DOI - PubMed

LinkOut - more resources